Clinical trial Recruiting at 1 site Observational Ages 50 to 80

Investigating the link between sleep apnea and cognitive decline in older adults

Official title: Exploring the Association Between Cognitive Function, Obstructive Sleep Apnea and Brain Imaging, and the Determinants of Neurocognitive Decline in Subjects With Subjective or Mild Cognitive Impairment

Run by The University of Hong Kong · NCT06150352 · Data updated 2026-11-12

This study is testing if treating sleep apnea with a CPAP machine can help older adults with mild memory problems maintain their thinking skills.

More Mild Cognitive Impairment trials

Quick facts

Study typeObservational
Ages50 Years to 80 Years
SexAll
Enrollment180 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedSeptember 26, 2023
Main results expectedDecember 30, 2026
Study endsMarch 31, 2027
Registry record updatedApril 2, 2025
Trial IDNCT06150352 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50 to 80 with mild cognitive impairment or subjective cognitive complaints who can read and speak Chinese.

Probably not a fit

Patients with diagnosed psychiatric illnesses or other clear organic causes of cognitive impairment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines the relationship between obstructive sleep apnea (OSA) and neurocognitive decline in individuals aged 50 to 80 with mild cognitive impairment or subjective cognitive complaints. It aims to determine if OSA is a contributing factor to cognitive decline and whether treatment with Continuous Positive Airway Pressure (CPAP) can mitigate this decline. Participants will undergo baseline PET-MRI brain scans to assess amyloid accumulation and neurocognitive status. The study seeks to identify modifiable factors that could improve cognitive function in affected individuals.

Why it matters

Potential benefit: If successful, this study could lead to improved cognitive outcomes for patients with mild cognitive impairment through targeted treatment of sleep apnea.

How similar studies have gone: Previous studies have suggested a link between sleep apnea and cognitive decline, indicating that this approach has potential but may still be novel in its specific focus.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 50 - 80 years
* Diagnosis of mild cognitive impairment based on Peterson's criteria.
* Diagnosis of subjective cognitive impairment, based on the subjective complaint of cognitive impairment, but with an unremarkable assessment of the Hong Kong version of Montreal cognitive Assessment scores
* Able to speak and read Chinese
* Adequate visual and auditory to perform a cognitive test
* Subjects with moderate-severe OSA or No OSA (diagnosis based on sleep study) would be invited for baseline PET-MRI brain scan

Exclusion Criteria:

* Diagnosed psychiatric illness with or without medication, e.g. major depressive disorder.
* Other clear organic causes of cognitive impairment, e.g. vascular cognitive impairment, brain tumour, dementia with Lewy body, mild cognitive impairment with Lewy body, Parkinson's disease, normal pressure hydrocephalus, neurosyphilis, autoimmune encephalitis, substance abuse, history of alcohol abuse.
* Diagnosis of cancer on active treatment
* Contraindications to PET-CT or MRI brain scan (excluded for neuroimaging studies)

Where it's running

  • Queen Mary Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Mary SM Ip, MD — School of Clinical Medicine, The University of Hong Kong
  • Study coordinator: Sau Man Mary Ip, MD
  • Email: msmip@hku.hk
  • Phone: 2255 5885

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.